Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
APTA Practice Advisory: Information Blocking

Jul 25, 2024/Resource

APTA's practice advisory helps practice owners and organization administrators, staff PTs and PTAs, and health IT developers understand the opportunities and implications of the information blocking rule.

Provider Enrollment, Chain and Ownership System

Jun 14, 2019/Open Access

PECOS supports the Medicare Provider and Supplier enrollment process by allowing registered users to securely and electronically submit and manage Medicare enrollment information.

Residency and Fellowship Education

Dec 1, 2019/Website

Explore residency and fellowship opportunities through the American Board of Physical Therapy Residency and Fellowship Education, or ABPTRFE.

2022 APTA Honors and Awards Recipients

May 20, 2022/Open Access

Congratulations to our 2022 recipients!

Role of Physical Therapy in Palliative Care and Hospice

Sep 20, 2019/Policies & Bylaws

House position: Outlines the role of physical therapy in palliative care and hospice settings.

Continuing Competence

Continuing Competence is the ongoing possession and application of contemporary knowledge and abilities commensurate with an individual's (physical therapist or physical therapist assistant) role within the context of public health, welfare, and safety.

Symptoms and Conditions

We have resources to support your evidence-based practice and improve your clinical decision-making. What was in PTNow is now on apta.org.

Autism Spectrum Disorder in Under 19s: Support and Management (Reviewed) [NICE CG170]

Jun 14, 2021/CPG

Covers the different ways that health and social care professionals can provide support and treatment for children and young people with autism, their families and carers.

Headaches in Over 12s: Diagnosis and Management [NICE CG150]

Dec 17, 2021/CPG

Evaluates the diagnosis and management of tension-type headache, migraine, cluster headache and medication overuse headache in adults and young people (aged 12 years and older).